A
Physician ReviewerMBBS, MD, DM (Endocrinology)

Dr. Ambrish Mithal, MD, DM (Endocrinology)

Chairman & Head, Endocrinology & Diabetes, Max Super Speciality Hospital

License VerifiedActive & In Good Standing

ID: DMC-14920

Delhi Medical Council (DMC) & National Medical Commission (NMC)

Professional Background & Bio

Dr. Ambrish Mithal is the Chairman and Head of Endocrinology and Diabetes at Max Super Speciality Hospital, Saket, New Delhi. A Padma Bhushan recipient and former faculty member at AIIMS New Delhi, Dr. Mithal is an internationally acclaimed authority on Type 2 Diabetes, osteoporosis, thyroid disorders, and metabolic health.

Medical Specialization

Endocrinology, Type 1 & Type 2 Diabetes, Thyroid Disorders, Bone Health & Osteoporosis

Clinical Experience

32+ Years Clinical Endocrinology & Academic Research

Hospital / Clinical Affiliation

Chairman & Head, Division of Endocrinology & Diabetes, Max Super Speciality Hospital, Saket, New Delhi

Education & Medical Training
  • DM in Endocrinology - All India Institute of Medical Sciences (AIIMS), New Delhi
  • MD in Internal Medicine - King George's Medical University (KGMU), Lucknow
  • MBBS - King George's Medical College, Lucknow

Academic Thesis & Medical Research

160+ Scientific Papers & Textbook Chapters
Postgraduate Thesis / Dissertation Title:

“Epidemiology of Hypovitaminosis D, Secondary Hyperparathyroidism, and Metabolic Bone Disease in Urban and Rural Indian Populations”

Institution: All India Institute of Medical Sciences (AIIMS), New Delhi

Landmark doctorate dissertation establishing the widespread prevalence of clinical and subclinical vitamin D deficiency across Indian demographics, establishing national diagnostic cutoffs and bone mineral density DEXA reference norms.

Key Investigative & Clinical Research Domains:
• Nutritional Rickets & Postmenopausal Osteoporosis• Incretin-Based Therapies in South Asian Type 2 Diabetes• Dual-Energy X-ray Absorptiometry (DEXA) Reference Ranges• Primary Hyperparathyroidism & Parathyroid Localization

Clinical Areas Reviewed for mediguide4u:

Type 2 Diabetes & Insulin ResistanceContinuous Glucose Monitoring & HbA1c ControlHypothyroidism, Hyperthyroidism & Thyroid NodulesOsteoporosis & Bone Mineral DensityMetabolic Syndrome & Dyslipidemia
Conflict-of-Interest & Editorial Independence Disclosure

Dr. Mithal reports no commercial relationships with pharmaceutical manufacturers. All reviews conform to ADA Standards of Care and Endocrine Society of India guidelines.

Articles Written by Dr. Ambrish Mithal, MD, DM (Endocrinology)

Educational healthcare resources created for public health literacy.

7 Authored
Type 2 Diabetes: Clinical Diagnosis, HbA1c Cutoffs, Pharmacotherapy, and Remission ProtocolsDiabetes
2026-08-0810 min read

Type 2 Diabetes: Clinical Diagnosis, HbA1c Cutoffs, Pharmacotherapy, and Remission Protocols

Type 2 Diabetes is a progressive metabolic disorder characterized by peripheral insulin resistance and progressive pancreatic beta-cell dysfunction. Explore current American Diabetes Association (ADA) diagnostic standards, modern cardioprotective medications (GLP-1 RAs and SGLT2 inhibitors), continuous glucose monitoring (CGM), and clinical diabetes remission protocols.

DiabetesRead Guide
Pre-Diabetes and Insulin Resistance: How to Lower Blood Glucose Before Type 2 DiabetesDiabetes
2026-08-089 min read

Pre-Diabetes and Insulin Resistance: How to Lower Blood Glucose Before Type 2 Diabetes

Prediabetes is a high-risk metabolic state affecting over 1 in 3 adults, characterized by peripheral insulin resistance and compensatory hyperinsulinemia. Explore clinical diagnostic cutoffs (HbA1c 5.7–6.4%, Fasting Glucose 100–125 mg/dL), HOMA-IR scoring, the landmark Diabetes Prevention Program (DPP) protocol, and skeletal muscle GLUT4 glucose disposal.

DiabetesRead Guide
Diabetic Neuropathy: Early Nerve Pain Symptoms, Foot Exams, and Blood Sugar ControlDiabetes
2026-08-089 min read

Diabetic Neuropathy: Early Nerve Pain Symptoms, Foot Exams, and Blood Sugar Control

Diabetic Peripheral Neuropathy (DPN) is the most common chronic microvascular complication of diabetes, affecting up to 50% of diabetic patients over their lifetime. Explore the biochemical mechanisms of neural glucotoxicity (polyol pathway sorbitol accumulation, microvascular vasa nervorum ischemia), clinical 10-g Semmes-Weinstein monofilament exams, and pharmacological pain management.

DiabetesRead Guide
Hypoglycemia (Low Blood Sugar): Symptoms, Rule of 15 Treatment, and Emergency CareDiabetes
2026-08-089 min read

Hypoglycemia (Low Blood Sugar): Symptoms, Rule of 15 Treatment, and Emergency Care

Hypoglycemia (blood glucose < 70 mg/dL) is an acute, potentially life-threatening endocrine emergency common in insulin- and sulfonylurea-treated diabetes. Explore the neuroendocrine response to falling glucose, autonomic vs. neuroglycopenic symptoms, the standardized clinical 'Rule of 15' treatment protocol, and emergency glucagon rescue.

DiabetesRead Guide